BioSpace News Archive

BioForest

Arizona Patients Successfully Receive the World’s First Bioconvertible IVC Filter Commercially Offered In US

BTG plc today announced the first patients outside of a clinical trial have been successfully implanted with the BTG Sentry device – the world’s first bioconvertible IVC filter.

December 3, 2018
·
3 min read
Are lungworms something you should know about?

Whether you take your dog or your cat to the vet, you have probably heard something about worms. Part of a complete pet health strategy includes protecting pets from the parasites in your area.

December 3, 2018
·
1 min read
Deals

Sangamo Announces Completion Of TxCell Acquisition

Sangamo Therapeutics, Inc. today announced the completion of the acquisition of TxCell, SA. TxCell is now a subsidiary of Sangamo and has been delisted from the French stock market.

December 3, 2018
·
4 min read
Job Trends

NantHealth® to Present New Research Findings at the San Antonio Breast Cancer Symposium

Topics to include DNA and RNA profiling and next-generation sequencing of tumors

December 3, 2018
·
5 min read
Business

KemPharm to Webcast Live at VirtualInvestorConferences.com on December 6th

KemPharm, Inc. today announced that its President and CEO, Travis Mickle, Ph.D., will present live at VirtualInvestorConferences.com on December 6, 2018.

December 3, 2018
·
3 min read
Business

Scientist.com Partners with Allele Biotech to Discover and Develop Therapeutic Nanoantibodies

Allele uses experts from Scientist.com’s Genius Consulting NetworkTM and proprietary internal technology to create innovative biologics programs

December 3, 2018
·
3 min read
MYM Announces $25,000,000 CDN Equity Investment

MYM Nutraceuticals Inc. is pleased to announce the Company has signed a term sheet for a $25 million equity investment by Alumina Partners LLC, a New York-based private equity firm that has made substantial investments in the cannabis space.

December 3, 2018
·
3 min read
Cardax and GNC Announce Expanded ZanthoSyn® Sales and Marketing Program

ZANTHOSYN® #1 AT GNC STORES IN HAWAII FOR PAST 12 MONTHS

December 3, 2018
·
4 min read
Biotech Bay

Eiger BioPharmaceuticals Announces FDA Acceptance of IND Application for Lonafarnib for the Treatment of Progeria and Progeroid Laminopathies

Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for lonafarnib

December 3, 2018
·
6 min read
Drug Development

WUGEN Presents Updated Preclinical Data on Novel Allogeneic CAR-T Platform at ASH Annual Meeting

WUGEN Inc., a biotechnology company developing a novel universal allogeneic CAR-T therapy platform, today announced updated preclinical data that validates its off-the-shelf fratricide-resistant CAR-T platform.

December 3, 2018
·
3 min read